MLXIPL and fatty liver disease: Since Nisch regulates the expression of ACSL3, PPARα, and CHREBP, activation of PPARα/AMPK expression of Nisch may be a novel approach to inhibit obesity and hepatic steatosis, and thus, Nisch may play an important role in obesity.